Trial Profile
A Phase II Study of Every 2 Week Doxil and Gemcitabine in Recurrent Ovarian Cancer
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 23 Apr 2007
Price :
$35
*
At a glance
- Drugs Doxorubicin liposomal (Primary)
- Indications Ovarian cancer
- Focus Adverse reactions
- 24 Nov 2006 New trial record.